Familial Mediterranean fever and atherosclerosis in childhood and adolescence

Olga Vampertzi1, Kyriaki Papadopoulou-Legbelou2, Areti Triantafyllou3

  • 14th Department of Pediatrics, "Papageorgiou" Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. olgastrieste@hotmail.com.

Rheumatology International
|November 10, 2019
PubMed

Insights

Familial Mediterranean Fever (FMF) patients may have ongoing inflammation, increasing risks for endothelial dysfunction and atherosclerosis. Early detection methods are crucial for managing cardiovascular disease in children with FMF.

Area of Science:

  • Rheumatology
  • Cardiology
  • Pediatrics

Background:

  • Familial Mediterranean Fever (FMF) is a chronic inflammatory condition causing recurrent fever and polyserositis.
  • Colchicine therapy manages FMF, but subclinical inflammation may persist, potentially leading to endothelial dysfunction and atherosclerosis.
  • Atherosclerosis is a significant long-term complication linked to chronic inflammatory diseases.

Purpose of the Study:

  • To review the association between FMF and atherosclerosis.
  • To explore novel serum inflammatory markers for FMF.
  • To identify non-invasive methods for early endothelial dysfunction detection in children with FMF.

Main Methods:

  • Systematic literature search of MEDLINE/PubMed, Scopus, and Web of Science.
  • Inclusion of peer-reviewed studies and reviews in English.
  • Keywords: familial Mediterranean fever, children, endothelial dysfunction, atherosclerosis, cardiovascular disease.

Main Results:

  • Evidence suggests a link between FMF and accelerated atherosclerosis.
  • Emerging inflammatory markers show promise in assessing disease activity.
  • Non-invasive techniques can detect early endothelial dysfunction.

Conclusions:

  • Subclinical inflammation in FMF contributes to cardiovascular risk.
  • Early identification of endothelial dysfunction and atherosclerosis in children with FMF is vital.
  • Further research into novel markers and non-invasive diagnostics is warranted for proactive cardiovascular care.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
413
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
723
Inflammation01:38

Inflammation

Overview
61.3K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
829
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
386
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
422